Buscar
Mostrando ítems 41-50 de 53
Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression
(Frontiers Research Foundation, 2022)
Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C
(Hindawi Publishing Corporation, 2019)
Hígado graso no alcohólico en consulta de gastroenterología
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2017-12-01)
Valor da elastografia hepática transitória isoladamente ou em associação a biomarcadores no estadiamento da doença hepática gordurosa não alcoólica
(Universidade Federal de São Paulo (UNIFESP), 2019-09-26)
Introduction: The prevalence of non-alcoholic fatty liver disease (NAFLD) has significantly increased in the world, affecting up to 30% of the Western population. It is associated with hepatic and systemic complications, ...
Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney diseaseEficacia y seguridad de los antivíricos de acción directa para el VHC en la nefropatía crónica de leve a moderada
(Sociedad Española de Nefrología Dr Rafael Matesanz, 2019-06)
BACKGROUND AND AIMS:The advent of direct-acting antiviral agents promises to change the management of hepatitis C virus infection (HCV) in patients with chronic kidney disease (CKD), a patient group in which the treatment ...
HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE
(Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE., 2018-12-01)
ABSTRACTBACKGROUND:Infection by hepatitis C virus is one of the leading causes of chronic hepatitis C and cause severe burden for patients, families and the health care system.OBJECTIVE:The aims of this research were to ...
Fibrose hepática e comprometimento neurológico em pacientes com Ataxia-telangiectasia: relação com resistência à insulina e inflamação
(Universidade Federal de São Paulo (UNIFESP), 2021)
Background: Ataxia-telangiectasia (A-T) is a DNA repair disorder characterized by alterations in several organs and systems. Advances in clinical protocols have resulted in increased survival of A-T patients, however disease ...